Gan Y, Yuan Z, Weng J, Huang M, Li T, Wu Y
BMC Biol. 2025; 23(1):61.
PMID: 40016751
PMC: 11866714.
DOI: 10.1186/s12915-025-02170-6.
Melino G, Bischof J, Chen W, Jia W, Juhl H, Kopeina G
Biol Direct. 2025; 20(1):14.
PMID: 39901154
PMC: 11792201.
DOI: 10.1186/s13062-025-00608-z.
Maurice M, Angers S
Nat Rev Mol Cell Biol. 2025; .
PMID: 39856369
DOI: 10.1038/s41580-024-00823-y.
Yang X, Chatterjee D, Couetil J, Liu Z, Ardon V, Chen C
Front Genet. 2024; 15:1410353.
PMID: 39678375
PMC: 11638177.
DOI: 10.3389/fgene.2024.1410353.
Klein-Scory S, Baraniskin A, Schmiegel W, Mika T, Schroers R, Held S
Mol Oncol. 2024; 19(2):344-356.
PMID: 39630848
PMC: 11793001.
DOI: 10.1002/1878-0261.13778.
Regulation of the Intestinal Stem Cell Pool and Proliferation in .
Trubin S, Patel D, Tian A
Cells. 2024; 13(22).
PMID: 39594605
PMC: 11592481.
DOI: 10.3390/cells13221856.
Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma.
Liu Z, Yang X, Chen S, Jia W, Qian Y, Zhang M
Sci Rep. 2024; 14(1):28039.
PMID: 39543336
PMC: 11564793.
DOI: 10.1038/s41598-024-78663-1.
Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort.
Reichmann R, Nimptsch K, Pischon T, Gunter M, Jenab M, Eriksen A
Int J Cancer. 2024; 156(5):930-942.
PMID: 39511728
PMC: 11701386.
DOI: 10.1002/ijc.35205.
Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis.
Zhuo L, Meng F, Sun K, Zhou M, Sun J
Br J Cancer. 2024; 131(6):1068-1079.
PMID: 39095528
PMC: 11405890.
DOI: 10.1038/s41416-024-02803-7.
Artificial Intelligence in Colorectal Cancer: From Patient Screening over Tailoring Treatment Decisions to Identification of Novel Biomarkers.
Reitsam N, Enke J, Vu Trung K, Markl B, Kather J
Digestion. 2024; 105(5):331-344.
PMID: 38865982
PMC: 11457979.
DOI: 10.1159/000539678.
Decoding bioactive signals of the RNA secretome: the cell-free messenger RNA catalogue.
De Sota R, Quake S, Sninsky J, Toden S
Expert Rev Mol Med. 2024; 26:e12.
PMID: 38682644
PMC: 11140549.
DOI: 10.1017/erm.2024.12.
CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.
Liu J, Zhang X, Yang M, Zhang X
J Cancer Res Clin Oncol. 2024; 150(4):211.
PMID: 38662258
PMC: 11045592.
DOI: 10.1007/s00432-024-05736-z.
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P, Pennel K, Alexander P, van Wyk H, Roseweir A, Inthagard J
J Pathol Clin Res. 2024; 10(3):e12374.
PMID: 38650367
PMC: 11035902.
DOI: 10.1002/2056-4538.12374.
Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.
Mouillet-Richard S, Cazelles A, Sroussi M, Gallois C, Taieb J, Laurent-Puig P
Clin Cancer Res. 2024; 30(11):2351-2358.
PMID: 38564259
PMC: 11145159.
DOI: 10.1158/1078-0432.CCR-23-3964.
Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer.
Luo Q, Quan Y, Liu W, Wu Z, Qiu W, Liang W
Cancer Manag Res. 2024; 16:225-243.
PMID: 38525373
PMC: 10961079.
DOI: 10.2147/CMAR.S441675.
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Pennel K, Hatthakarnkul P, Wood C, Lian G, Al-Badran S, Quinn J
J Exp Clin Cancer Res. 2024; 43(1):64.
PMID: 38424636
PMC: 10905886.
DOI: 10.1186/s13046-024-02958-4.
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
Chen L, Wang Y, Cai C, Ding Y, Kim R, Lipchik C
J Clin Oncol. 2024; 42(13):1520-1530.
PMID: 38315963
PMC: 11095904.
DOI: 10.1200/JCO.23.01080.
CircPOFUT1 fosters colorectal cancer metastasis and chemoresistance via decoying miR-653-5p/E2F7/WDR66 axis and stabilizing BMI1.
Long F, Tian B, Li L, Ma M, Chen Z, Tan G
iScience. 2024; 27(1):108729.
PMID: 38230259
PMC: 10790033.
DOI: 10.1016/j.isci.2023.108729.
Hsa_circ_0001278 Facilitates Colorectal Cancer Progression Sponging miR-338-5p and Regulating AMOTL1 Expression.
Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X
Comb Chem High Throughput Screen. 2023; 28(1):99-109.
PMID: 38018210
DOI: 10.2174/0113862073265207231108052536.
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer.
Quan Y, He J, Zou Q, Zhang L, Sun Q, Huang H
J Immunother Cancer. 2023; 11(8).
PMID: 37597850
PMC: 10441131.
DOI: 10.1136/jitc-2023-007080.
